|
1
|
Collard CD and Gelman S: Pathophysiology,
clinical manifestations, and prevention of ischemia-reperfusion
injury. Anesthesiology. 94:1133–1138. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Grootjans J, Lenaerts K, Derikx JP,
Matthijsen RA, de Bruïne AP, van Bijnen AA, van Dam RM, Dejong CH
and Buurman WA: Human intestinal ischemia-reperfusion-induced
inflammation characterized: experiences from a new translational
model. Am J Pathol. 176:2283–2291. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Andrade ME, Araújo RS, de Barros PA,
Soares AD, Abrantes FA, Generoso SV, Fernandes SO and Cardoso VN:
The role of immunomodulators on intestinal barrier homeostasis in
experimental models. Clin Nutr. 34:1080–1087. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Andres SF, Simmons JG, Mah AT, Santoro MA,
Van Landeghem L and Lund PK: Insulin receptor isoform switching in
intestinal stem cells, progenitors, differentiated lineages and
tumors: evidence that IR-B limits proliferation. J Cell Sci.
126:5645–5656. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Beagley KW, Fujihashi K, Lagoo AS,
Lagoo-Deenadaylan S, Black CA, Murray AM, Sharmanov AT, Yamamoto M,
McGhee JR, Elson CO, et al: Differences in intraepithelial
lymphocyte T cell subsets isolated from murine small versus large
intestine. J Immunol. 154:5611–5619. 1995.PubMed/NCBI
|
|
6
|
Cheroutre H, Lambolez F and Mucida D: The
light and dark sides of intestinal intraepithelial lymphocytes. Nat
Rev Immunol. 11:445–456. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Qiu Y, Yu M, Yang Y, Sheng H, Wang W, Sun
L, Chen G, Liu Y, Xiao W and Yang H: Disturbance of intraepithelial
lymphocytes in a murine model of acute intestinal
ischemia̸reperfusion. J Mol Histol. 45:217–227. 2014. View Article : Google Scholar
|
|
8
|
Qiu Y and Yang H: Effects of
intraepithelial lymphocyte-derived cytokines on intestinal mucosal
barrier function. J Interferon Cytokine Res. 33:551–562. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Miyazono K, Kamiya Y and Morikawa M: Bone
morphogenetic protein receptors and signal transduction. J Biochem.
147:35–51. 2010. View Article : Google Scholar
|
|
10
|
Core AB, Canali S and Babitt JL:
Hemojuvelin and bone morphogenetic protein (BMP) signaling in iron
homeostasis. Front Pharmacol. 5:1042014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang C, Feng Y, Yang H, Koga H and
Teitelbaum DH: The bone morphogenetic protein signaling pathway is
upregulated in a mouse model of total parenteral nutrition. J Nutr.
139:1315–1321. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen K, Xie W, Luo B, Xiao W, Teitelbaum
DH, Yang H, Zhang K and Zhang C: Intestinal mucosal barrier is
injured by BMP2/4 via activation of NF-κB signals after ischemic
reperfusion. Mediators Inflamm. 2014:9015302014. View Article : Google Scholar
|
|
13
|
Yoshioka Y, Ono M, Osaki M, Konishi I and
Sakaguchi S: Differential effects of inhibition of bone morphogenic
protein (BMP) signalling on T-cell activation and differentiation.
Eur J Immunol. 42:749–759. 2012. View Article : Google Scholar
|
|
14
|
Hager-Theodorides AL, Ross SE, Sahni H,
Mishina Y, Furmanski AL and Crompton T: Direct BMP2/4 signaling
through BMP receptor IA regulates fetal thymocyte progenitor
homeostasis and differentiation to CD4+CD8+
double-positive cell. Cell Cycle. 13:324–333. 2014. View Article : Google Scholar
|
|
15
|
Varas A, Sacedón R, Hidalgo L, Martínez
VG, Valencia J, Cejalvo T, Zapata A, Hernández-López C and Vicente
A: Interplay between BMP4 and IL-7 in human intrathymic precursor
cells. Cell Cycle. 8:4119–4126. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gerondakis S, Fulford TS, Messina L and
Grumont RJ: NF-κB control of T cell development. Nat Immunol.
15:15–25. 2014. View
Article : Google Scholar
|
|
17
|
Fan Z, Jing H, Yao J, Li Y, Hu X, Shao H,
Shen G, Pan J, Luo F and Tian X: The protective effects of curcumin
on experimental acute liver lesion induced by intestinal
ischemia-reperfusion through inhibiting the pathway of NF-κB in a
rat model. Oxid Med Cell Longev. 2014:1916242014. View Article : Google Scholar
|
|
18
|
Kim GY, Hong C and Park JH: Seeing is
believing: illuminating the source of in vivo interleukin-7. Immune
Netw. 11:1–10. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sprent J and Surh CD: Normal T cell
homeostasis: the conversion of naive cells into memory-phenotype
cells. Nat Immunol. 12:478–484. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chetoui N, Boisvert M, Gendron S and
Aoudjit F: Interleukin-7 promotes the survival of human
CD4+ effector/memory T cells by up-regulating Bcl-2
proteins and activating the JAK/STAT signalling pathway.
Immunology. 130:418–426. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tal N, Shochat C, Geron I, Bercovich D and
Izraeli S: Interleukin 7 and thymic stromal lymphopoietin: from
immunity to leukemia. Cell Mol Life Sci. 71:365–378. 2014.
View Article : Google Scholar
|
|
22
|
Carrette F and Surh CD: IL-7 signaling and
CD127 receptor regulation in the control of T cell homeostasis.
Semin Immunol. 24:209–217. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Monneret G, Villars-Méchin A, Demaret J,
Foray AP and Venet F: Interleukin-7, a new immunoadjuvant for the
treatment of septic shock. Med Sci (Paris). 30:160–165. 2014.In
French. View Article : Google Scholar
|
|
24
|
Geiselhart LA, Humphries CA, Gregorio TA,
Mou S, Subleski J and Komschlies KL: IL-7 administration alters the
CD4:CD8 ratio, increases T cell numbers, and increases T cell
function in the absence of activation. J Immunol. 166:3019–3027.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cai YJ, Wang WS, Yang Y, Sun LH,
Teitelbaum DH and Yang H: Up-regulation of intestinal epithelial
cell derived IL-7 expression by keratinocyte growth factor through
STAT1/IRF-1, IRF-2 pathway. PLoS one. 8:e586472013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang H, Gumucio DL and Teitelbaum DH:
Intestinal specific overexpression of interleukin-7 attenuates the
alternation of intestinal intraepithelial lymphocytes after total
parenteral nutrition administration. Ann Surg. 248:849–856. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shitara S, Hara T, Liang B, Wagatsuma K,
Zuklys S, Holländer GA, Nakase H, Chiba T, Tani-ichi S and Ikuta K:
IL-7 produced by thymic epithelial cells plays a major role in the
development of thymocytes and TCRγδ+ intraepithelial
lymphocytes. J Immunol. 190:6173–6179. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mosley RL and Klein JR: A rapid method for
isolating murine intestine intraepithelial lymphocytes with high
yield and purity. J Immunol Methods. 156:19–26. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Vollmar B and Menger MD: Intestinal
ischemia/reperfusion: microcirculatory pathology and functional
consequences. Langenbecks Arch Surg. 396:13–29. 2011. View Article : Google Scholar
|
|
30
|
Ji T, Xu C, Sun L, Yu M, Peng K, Qiu Y,
Xiao W and Yang H: Aryl hydrocarbon receptor activation
down-regulates IL-7 and reduces inflammation in a mouse model of
DSS-induced colitis. Dig Dis Sci. 60:1958–1966. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cai YJ, Wang WS, Liang HY, Sun LH,
Teitelbaum DH and Yang H: Keratinocyte growth factor up-regulates
interleukin-7 expression following intestinal ischemia/reperfusion
in vitro and in vivo. Int J Clin Exp Pathol. 5:569–580.
2012.PubMed/NCBI
|
|
32
|
Jain AP, Pundir S and Sharma A: Bone
morphogenetic proteins: the anomalous molecules. J Indian Soc
Periodontol. 17:583–586. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bandyopadhyay A, Yadav PS and Prashar P:
BMP signaling in development and diseases: a pharmacological
perspective. Biochem Pharmacol. 85:857–864. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bruun C, Christensen GL, Jacobsen ML,
Kanstrup MB, Jensen PR, Fjordvang H, Mandrup-Poulsen T and
Billestrup N: Inhibition of beta cell growth and function by bone
morphogenetic proteins. Diabetologia. 57:2546–2554. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yan R, Li Y, Zhang L, Xia N, Liu Q, Sun H
and Guo H: Augmenter of liver regeneration attenuates inflammation
of renal ischemia/reperfusion injury through the NF-kappa B pathway
in rats. Int Urol Nephrol. 47:861–868. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Park JH, Yu Q, Erman B, Appelbaum JS,
Montoya-Durango D, Grimes HL and Singer A: Suppression of IL7Ralpha
transcription by IL-7 and other prosurvival cytokines: a novel
mechanism for maximizing IL-7-dependent T cell survival. Immunity.
21:289–302. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Henriques CM, Rino J, Nibbs RJ, Graham GJ
and Barata JT: IL-7 induces rapid clathrin-mediated internalization
and JAK3-dependent degradation of IL-7Ralpha in T cells. Blood.
115:3269–3277. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Jiang Q, Li WQ, Aiello FB, Mazzucchelli R,
Asefa B, Khaled AR and Durum SK: Cell biology of IL-7, a key
lymphotrophin. Cytokine Growth Factor Rev. 16:513–533. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Jacobs SR, Michalek RD and Rathmell JC:
IL-7 is essential for homeostatic control of T cell metabolism in
vivo. J Immunol. 184:3461–3469. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Miller ML, Mashayekhi M, Chen L, Zhou P,
Liu X, Michelotti M, Tramontini Gunn N, Powers S, Zhu X, Evaristo
C, et al: Basal NF-κB controls IL-7 responsiveness of quiescent
naïve T cells. Proc Natl Acad Sci USA. 111:7397–7402. 2014.
View Article : Google Scholar
|
|
41
|
Silva A, Cornish G, Ley SC and Seddon B:
NF-κB signaling mediates homeostatic maturation of new T cells.
Proc Natl Acad Sci USA. 111:E846–E855. 2014. View Article : Google Scholar
|
